Bactiguard Holding AB (publ) (STO:BACTI.B)
Sweden · Delayed Price · Currency is SEK 16.80
+1.15 (7.35%)
At close: Dec 5, 2025
Bactiguard Holding AB Revenue
Bactiguard Holding AB had revenue of 45.46M SEK in the quarter ending September 30, 2025, a decrease of -32.47%. This brings the company's revenue in the last twelve months to 217.83M, down -5.44% year-over-year. In the year 2024, Bactiguard Holding AB had annual revenue of 243.68M with 19.46% growth.
Revenue (ttm)
217.83M
Revenue Growth
-5.44%
P/S Ratio
2.70
Revenue / Employee
1.39M
Employees
177
Market Cap
588.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 243.68M | 39.69M | 19.46% |
| Dec 31, 2023 | 203.99M | -22.73M | -10.03% |
| Dec 31, 2022 | 226.72M | 54.55M | 31.69% |
| Dec 31, 2021 | 172.17M | -4.40M | -2.49% |
| Dec 31, 2020 | 176.57M | -13.11M | -6.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Bactiguard Holding AB News
- 6 weeks ago - Bactiguard Holding AB (STU:5JE) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 6 weeks ago - Q3 2025 Bactiguard Holding AB Earnings Call Transcript - GuruFocus